Miami Herald, May 24, 2016. The U.S. Food and Drug Administration is expected to decide this week whether to approve a new weapon in the war against heroin and prescription opioid addiction. The Probuphine implant by Braeburn Pharmaceuticals of Princeton, NJ, would be the first FDA-approved implant for opioid dependence and the longest-acting treatment to address the growing problem.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
US Healthcare: Power to the Patients?
Financial Times, May 22, 2016. Families of boys suffering from Duchenne muscular dystrophy push for approval of a new medicine because there are no other treatments. But scientists point out that there is no evidence that the drug works. Does it set a dangerous precedent for FDA to approve a new drug based on patients’ claims rather than science?
Read More »Why We Shouldn’t Trade a Weakened FDA for More Medical Research Funds
STAT, May 17, 2016. There is no question that more research funding is necessary and that finding legitimate ways to get medicines to patients faster is crucial. But Congress ought to separate the debate over research funding from the rest of the legislation. Loosening regulatory standards would only create problems for which real cures will be needed.
Read More »Experts Decry Tying Medical Research Funds to FDA Standards Changes
Wall Street Journal, May 12, 2016. Moves in Congress to link billions of dollars in new medical research funding to revised standards for drug and medical-device approvals are troubling some public-health experts, who say the combination makes it too easy for lawmakers to support lower patient-safety standards.
Read More »2016 Foremother and Health Policy Hero Awards Luncheon
May 12, 2016. This year’s awards luncheon was held at the historic Mayflower Hotel in Washington DC. We honored Judy Woodruff, Elaine Jones, and Nancy Pelosi as Foremothers and Flint, Michigan heroes LeeAnne Walters and Marc Edwards as Health Policy Heroes. It was a huge success and a wonderful honor to be able to hear from such inspirational leaders!
Read More »